Evidence map›Paper›PMID 30082713›Full record

ReviewEmerging microbes & infections2018

An update on the human and animal enteric pathogen Clostridium perfringens.

Raymond Kiu, Lindsay J Hall

Open access · goldAbstract readReview
In one paragraph

Review in Emerging microbes & infections, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 247 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
247citing papers in PubMed, 1 pooled it
20.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

247 citing papers in PubMed, 1 synthesis or guideline pooled it, 423 citations in OpenAlex.

  1. Pooled it
  2. Dietary Sanguinarine MitigatesLife (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Isolation, Genomic Evolution, and Pathogenicity ofAnimals : an open access journal from MDPI · 2026
    Article
  5. Fatal Acute Thyroiditis in a Giraffe (Animals : an open access journal from MDPI · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Acta pharmaceutica Sinica. B · 2026
    Article
  14. Article
  15. Article
  16. A novel broad-spectrum phage lysin CP02 for biocontrol ofCurrent research in food science · 2026
    Article
  17. Article
  18. Type A and DFrontiers in cellular and infection microbiology · 2026
    Article
  19. Article
  20. A novel typing method forFrontiers in microbiology · 2026
    Article

187 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Raymond KiuGut Microbes and Health Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.ORCID http://orcid.org/0000-0002-4483-1215
Lindsay J HallGut Microbes and Health Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK. Lindsay.Hall@quadram.ac.uk.ORCID http://orcid.org/0000-0001-8938-5709
Norwich Research Park · GBUniversity of East Anglia · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/F/00044409Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10353Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10356Biotechnology and Biological Sciences Research Council (BBSRC) BB/J004529/1Wellcome TrustWellcome Trust 100974/C/13/Z
6 · The paper itself

Abstract

Clostridium perfringens, a rapid-growing pathogen known to secrete an arsenal of >20 virulent toxins, has been associated with intestinal diseases in both animals and humans throughout the past century. Recent advances in genomic analysis and experimental systems make it timely to re-visit this clinically and veterinary important pathogen. This Review will summarise our understanding of the genomics and virulence-linked factors, including antimicrobial potentials and secreted toxins of this gut pathogen, and then its up-to-date clinical epidemiology and biological role in the pathogenesis of several important human and animal-associated intestinal diseases, including pre-term necrotising enterocolitis. Finally, we highlight some of the important unresolved questions in relation to C. perfringens-mediated infections, and implications for future research directions.

Indexed as

AnimalsBacterial ProteinsBacterial ToxinsClostridium InfectionsClostridium perfringensHumansVirulenceBacterial ProteinsBacterial Toxins

Identifiers

PMID30082713
PMCPMC6079034
OpenAlexW2885835166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.